Allergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
L. Perrigo's Allergy Relief 180 mg tablets are being recalled due to failed impurity and degradation specifications. The recall affects 32,904 cartons distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a drug recall for failed impurity and degradation specifications with no reported illnesses or injuries. Per the rubric, a risk-of-harm product where injury has not yet been reported qualifies for a score of 3 (High).
Plain-English summary
L. Perrigo Company is recalling Allergy Relief Fexofenadine Hydrochloride Tablets (180 mg) due to failed impurity and degradation specifications. The affected product was distributed nationwide by Publix Super Markets, Inc.
The recall affects 32,904 cartons in two package sizes: 30-count and 45-count cartons. Affected lot numbers include 2CR0652, 2DR0464, and 2DR0465 (expiration 12/23); 2ER0285 (expiration 01/24); 2DR0466 (expiration 12/23); 2ER0412 (expiration 01/24); and 2GR0330 (expiration 04/24).
Consumers who have purchased this product should stop using it and return the cartons to their point of purchase. For questions about your allergy medication, speak with a healthcare provider or pharmacist.
The recalled product
- Product
- ALLERGY RELIEF (FEXOFENADINE HYDROCHLORIDE)
- Brand
- ALLERGY RELIEF
- Manufacturer
- L. Perrigo Company
- Category
- Drug — OTC Antihistamine
- Hazard
- Affected units
- 32,904
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: a) 2CR0652
- 2DR0464
- 2DR0465
- Exp. Date 12/23
- 2ER0285
- Exp. Date 01/24. b) 2DR0466
- 2ER0412
- Exp. Date 01/24
- 2GR0330
- Exp. Date 04/24
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by L. Perrigo Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same brand · ALLERGY RELIEF
- ModerateOTC Allergy Relief Medication Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- ModerateOhm Allergy Relief Loratadine Recalled for Out-of-Specification Assay
FDA (Drugs) · 2015-10-21
Same manufacturer · L. Perrigo Company
See all →- HighFexofenadine Tablets Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Antihistamine Tablets Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same hazard · impurity
See all →- ModerateAjanta Pharma Recalls Fluphenazine Hydrochloride Tablets Due to Impurity Failure
FDA (Drugs) · 2026-09-16
- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
Similar recalls
- ModerateAllergyrelief Fexofenadine Tablets Recalled for Impurity Specification Failure
FDA (Drugs) · 2022-01-12
- ModerateCVS Allergy Relief Fexofenadine Tablets Recalled for Impurity Specifications
FDA (Drugs) · 2022-01-12
- ModerateH.E.B Allergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2022-01-12
- ModerateCAREONE Allergy Relief 180 mg Tablets Recalled for Failed Impurities Specifications
FDA (Drugs) · 2022-01-12
- ModerateRite Aid Allergy Relief Fexofenadine tablets recalled for impurity
FDA (Drugs) · 2022-01-12
- ModerateTopCare Allergy Relief Fexofenadine tablets recalled for impurity specifications
FDA (Drugs) · 2022-01-12